Open Access · CC BY-NC 4.0
Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”
Liver Cancer · 14.11.2026
DOI: 10.1159/lic/admag028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Cancer, online erschienen am 14.11.2026. Verfasst von Chi Xu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Xu, C., Sun, J., Liang, Q., Zhou, K., & Pan, J. (2026). Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”. Liver Cancer. https://doi.org/10.1159/lic/admag028
Vancouver
Xu C, Sun J, Liang Q, Zhou K, Pan J. Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”. Liver Cancer. 2026. doi:10.1159/lic/admag028
BibTeX
@article{Xu2026,
author = {Xu, Chi and Sun, Jiapeng and Liang, Qiongyu and Zhou, Kang and Pan, Jie},
title = {Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”},
journal = {Liver Cancer},
year = {2026},
doi = {10.1159/lic/admag028}
}
EUVIMED